Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850681 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
A Phase 1 study of Actinic Keratosis, sponsored by Peplin.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00850681: Completed Phase 1 study of Actinic Keratosis, sponsored by Peplin.
NCT00850681 is a Phase 1 study of Actinic Keratosis that has completed, run by Peplin. The registered enrollment target is 50 participants, below the 186-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00850681, a Phase 1 study of Actinic Keratosis, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin.
Conditions Studied
Interventions
- DRUG PEP005 (ingenol mebutate) Gel
Study Locations (1)
New Jersey
- TKL Research, Inc. - Paramus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
What the finished NCT00850681 record still lists
NCT00850681 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 186-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Actinic Keratosis appearing as the primary indexed condition, and to 1 intervention - of which PEP005 (ingenol mebutate) Gel is the first listed.
NCT00850681 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00850681 about?
NCT00850681 is a clinical study titled "A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers". This Phase 1 study is designed to determine the photoallergic potential of PEP005 Gel, 0.01% and it's vehicle on normal skin.
What is the current status of trial NCT00850681?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2009-02. Estimated completion is 2009-04.
What conditions does trial NCT00850681 study?
This clinical trial studies the following conditions: Actinic Keratosis.
What interventions are being tested in trial NCT00850681?
The interventions under investigation include: PEP005 (ingenol mebutate) Gel (DRUG).
Who is sponsoring clinical trial NCT00850681?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00850681 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00850681's enrollment target sits among peer trials
50 12th of 16 higher than 5 of 16 other Actinic Keratosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Actinic Keratosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
RECRUITING · Phase 1
-
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
COMPLETED · Phase 1
-
Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis
COMPLETED · Phase 1
-
The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
RECRUITING · Phase 2
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
ACTIVE NOT RECRUITING · Phase 3
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia